BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 38133816)

  • 1. Roles of Apigenin and Nepetin in the Assembly Behavior and Cytotoxicity of Prion Neuropeptide PrP106-126.
    Huo Y; Zhao C; Wang Y; Wang S; Mu T; Du W
    ACS Chem Neurosci; 2024 Jan; 15(2):245-257. PubMed ID: 38133816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of sesquiterpene lactones on the aggregation and cytotoxicity of prion neuropeptide.
    Huo Y; Huang X; Wang Y; Zhao C; Zheng T; Du W
    Biochimie; 2023 Aug; 211():131-140. PubMed ID: 36963557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory effects of NAMI-A-like ruthenium complexes on prion neuropeptide fibril formation.
    Wang X; Zhu D; Zhao C; He L; Du W
    Metallomics; 2015 May; 7(5):837-46. PubMed ID: 25856332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gold complexes inhibit the aggregation of prion neuropeptides.
    Wang X; He L; Zhao C; Du W; Lin J
    J Biol Inorg Chem; 2013 Oct; 18(7):767-78. PubMed ID: 23982344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of human prion neuropeptide PrP106-126 aggregation by hexacoordinated ruthenium complexes.
    Wang X; Zhang B; Zhao C; Wang Y; He L; Cui M; Zhu X; Du W
    J Inorg Biochem; 2013 Nov; 128():1-10. PubMed ID: 23911565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular determinants of the physicochemical properties of a critical prion protein region comprising residues 106-126.
    Salmona M; Malesani P; De Gioia L; Gorla S; Bruschi M; Molinari A; Della Vedova F; Pedrotti B; Marrari MA; Awan T; Bugiani O; Forloni G; Tagliavini F
    Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):207-14. PubMed ID: 10432318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of aggregation behavior and neurotoxicity of prion neuropeptides by platinum complexes.
    Wang X; Cui M; Zhao C; He L; Zhu D; Wang B; Du W
    Inorg Chem; 2014 May; 53(10):5044-54. PubMed ID: 24787240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance of nepetin and its analogs on the fibril formation of human islet amyloid polypeptide.
    Xu J; Zheng T; Zhao C; Huang X; Du W
    Int J Biol Macromol; 2021 Jan; 166():435-447. PubMed ID: 33127549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock protein 104 inhibited the fibrillization of prion peptide 106-126 and disassembled prion peptide 106-126 fibrils in vitro.
    Liu YH; Han YL; Song J; Wang Y; Jing YY; Shi Q; Tian C; Wang ZY; Li CP; Han J; Dong XP
    Int J Biochem Cell Biol; 2011 May; 43(5):768-74. PubMed ID: 21296677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of gold-bipyridyl derivants on aggregation and disaggregation of the prion neuropeptide PrP106-126.
    Zhao C; Wang X; He L; Zhu D; Wang B; Du W
    Metallomics; 2014 Nov; 6(11):2117-25. PubMed ID: 25273168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prion peptide uptake in microglial cells--the effect of naturally occurring autoantibodies against prion protein.
    Roettger Y; Zerr I; Dodel R; Bach JP
    PLoS One; 2013; 8(6):e67743. PubMed ID: 23840767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of the 5-lipoxygenase pathway in the neurotoxicity of the prion peptide PrP106-126.
    Stewart LR; White AR; Jobling MF; Needham BE; Maher F; Thyer J; Beyreuther K; Masters CL; Collins SJ; Cappai R
    J Neurosci Res; 2001 Sep; 65(6):565-72. PubMed ID: 11550224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion protein fragment 106-126 induces a p38 MAP kinase-dependent apoptosis in SH-SY5Y neuroblastoma cells independently from the amyloid fibril formation.
    Corsaro A; Thellung S; Villa V; Principe DR; Paludi D; Arena S; Millo E; Schettini D; Damonte G; Aceto A; Schettini G; Florio T
    Ann N Y Acad Sci; 2003 Dec; 1010():610-22. PubMed ID: 15033801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sublethal concentrations of prion peptide PrP106-126 or the amyloid beta peptide of Alzheimer's disease activates expression of proapoptotic markers in primary cortical neurons.
    White AR; Guirguis R; Brazier MW; Jobling MF; Hill AF; Beyreuther K; Barrow CJ; Masters CL; Collins SJ; Cappai R
    Neurobiol Dis; 2001 Apr; 8(2):299-316. PubMed ID: 11300725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p75(NTR) activation of NF-kappaB is involved in PrP106-126-induced apoptosis in mouse neuroblastoma cells.
    Bai Y; Li Q; Yang J; Zhou X; Yin X; Zhao D
    Neurosci Res; 2008 Sep; 62(1):9-14. PubMed ID: 18602709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-mediated inhibition of integrin α5β1 blocks neurotoxic prion peptide PrP106-126-induced activation of BV2 microglia.
    Chang J; Yang L; Kouadir M; Peng Y; Zhang S; Shi F; Zhou X; Yin X; Zhao D
    J Mol Neurosci; 2012 Sep; 48(1):248-52. PubMed ID: 22648512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Palladium complexes affect the aggregation of human prion protein PrP106-126.
    Wang Y; Feng L; Zhang B; Wang X; Huang C; Li Y; Du W
    Inorg Chem; 2011 May; 50(10):4340-8. PubMed ID: 21504185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
    Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
    Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular uptake of the prion protein fragment PrP106-126 in vitro.
    McHattie SJ; Brown DR; Bird MM
    J Neurocytol; 1999 Feb; 28(2):149-59. PubMed ID: 10590514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The neurotoxicity of prion protein (PrP) peptide 106-126 is independent of the expression level of PrP and is not mediated by abnormal PrP species.
    Fioriti L; Quaglio E; Massignan T; Colombo L; Stewart RS; Salmona M; Harris DA; Forloni G; Chiesa R
    Mol Cell Neurosci; 2005 Jan; 28(1):165-76. PubMed ID: 15607951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.